Search

Your search keyword '"Tamura, S"' showing total 127 results

Search Constraints

Start Over You searched for: Author "Tamura, S" Remove constraint Author: "Tamura, S" Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
127 results on '"Tamura, S"'

Search Results

1. A PHASE 2 TRIAL OF CHOP WITH ANTI‐CCR4 ANTIBODY MOGAMULIZUMAB FOR ELDERLY PATIENTS WITH CCR4‐POSITIVE ADULT T‐CELL LEUKEMIA/LYMPHOMA.

2. Optimisation of antithrombin resistance assay as a practical clinical laboratory test: Development of prothrombin activator using factors Xa/Va and automation of assay.

3. Combined deficiency of factors V and VIII by chance coinheritance of parahaemophilia and haemophilia A, but not by mutations of either <italic>LMAN1</italic> or <italic>MCFD2,</italic> in a Japanese family.

4. The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1.

5. Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.

6. The basis examination of leukocyte-platelet aggregates with CD45 gating as a novel platelet activation marker.

8. GM2 Gangliosidosis Variant 0 (Sandhoff-Like Disease) in a Family of Toy Poodles.

9. Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses.

10. Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders.

11. Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin.

12. Pegylated interferon alpha-2b (Peg-IFN α-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN α-2b plus ribavirin.

13. Effect of heat treatment and enzymatic digestion on the B cell epitopes of cow's milk proteins.

14. Inhibiting effects of Streptococcus salivarius on competence-stimulating peptide-dependent biofilm formation by Streptococcus mutans.

15. Antithrombin effect on coagulation and fibrinolytic profiles after living donor liver transplantation: a pilot study.

16. Pseudomonas aeruginosa infection after living-donor liver transplantation in adults.

17. Methicillin-resistant Staphylococcus aureus infection after living-donor liver transplantation in adults.

18. Magnetic resonance imaging findings of neuroaxonal dystrophy in a papillon puppy.

19. Successful treatment of disseminated Nocardia farcinica infection in a living-donor liver transplantation recipient.

20. Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy.

23. Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death.

24. Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay.

26. Preferential induction of memory T cells for delayed-type hypersensitivity with reduced and alkylated human serum albumin in mice.

27. Regulatory role of suppressor T cells in the expression of delayed-type hypersensitivity in mice. II. SOLUBLE FACTOR FROM THYMIC SUPPRESSOR CELLS STIMULATED WITH ANTIGEN <em> IN VITRO</em> AND ITS POSSIBLE INTERACTION WITH MACROPHAGES.

28. Cellular and humoral immune responses in mice III. ACCELERATION OF DELAYED HYPERSENSITIVITY RESPONSE BY PRESENSITIZATION WITH SUBOPTIMAL DOSE OF ANTIGEN.

29. <em>H-2</em>-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin.

30. Effect of high doses of synthetic estrogen on lipid metabolism in castrated male rats.

34. Tumor markers in pleural effusion diagnosis.

39. Recombinant interferon-α-2a for treatment of chronic hepatitis C: results of a multicenter randomized controlled dose study.

42. CONSOLIDATION THERAPY USING 90Y‐IBRITUMOMAB TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB FOR RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRiZ2012).

43. Multiple metastases of thyroid cancer in the cranium and pituitary gland in two dogs.

Catalog

Books, media, physical & digital resources